Testosterone

Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes

Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes

By

At 12 years of testosterone treatment, HbA1c decreased to 5.5±0.3%.

Increasing Bone Mineral Density in Older Men

Increasing Bone Mineral Density in Older Men

By

After 1 year of therapy, men who underwent testosterone therapy experienced improvement in bone mineral density and mood.

Case Study: Adverse Cerebrovascular Event With Testosterone Use

Case Study: Adverse Cerebrovascular Event With Testosterone Use

By

A 28-year-old male patient, otherwise in good health, presented with acute onset vertigo, nausea, and vomiting resulting from exogenous testosterone use.

Testosterone May Explain Gender Disparity in Rates of Asthma

Testosterone May Explain Gender Disparity in Rates of Asthma

Testosterone has been identified as a "potent inhibitor" of lymphoid cells responsible for producing proteins that lead to lung inflammation.

Sign Up for Free e-Newsletters

CME Focus